Atlas Trials

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Clinical trial NCT05690386 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05690386
Sponsor
Ascendis Pharma Endocrinology Division A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Turner Syndrome
Start date
2023-02-15
Primary completion
2024-10-18
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.